|Articles|June 28, 2016

DrugDev Launches CRO Program with INC Research

DrugDev has launched its CRO Preferred Partner program alongside Charter Member INC Research.

DrugDev has launched its CRO Preferred Partner program alongside Charter Member INC Research. Sponsors will be offered use of DrugDevs Golden Number, used to match and master data from disparate sources, and the new DrugDev patient engagment solution, which enables sites to send information, documents and notifications to patients via SMS.

Read the full release here

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

DrugDev Launches CRO Program with INC Research

Related Content

PLPS Launches MyClinicalSuite™ to Deliver Faster Clinical Trial Label Turnarounds Without Compromising Quality, Compliance, or Patient Safety

What Clinical Trials Can Learn from the Gig Economy About Payments

How the Line Between Clinical Data and Real-World Evidence Is Blurring

ACT Brief: RBQM Financial Value Quantified, Sponsor-Configurable AI Systems, and Basket Trials for Rare Pediatrics

Quantifying the Net Financial Value of Deploying Risk-Based Quality Management

Trending on Applied Clinical Trials Online

Quantifying the Net Financial Value of Deploying Risk-Based Quality Management

ACT Brief: RBQM Financial Value Quantified, Sponsor-Configurable AI Systems, and Basket Trials for Rare Pediatrics

AI-Driven Clinical Trial Recruitment and Design

ACT Brief: Quality Built Throughout Trial Lifecycle, Agentic RTSM Compression, and State Access Programs

PLPS Launches MyClinicalSuite™ to Deliver Faster Clinical Trial Label Turnarounds Without Compromising Quality, Compliance, or Patient Safety